GOLDMAN SACHS GROUP INC - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 50 filers reported holding VINCERX PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$2,083,555
-22.3%
2,062,926
-0.0%
0.00%
-100.0%
Q2 2023$2,681,835
+24.9%
2,062,950
-0.1%
0.00%
Q1 2023$2,147,488
+1.5%
2,064,892
-0.5%
0.00%
Q4 2022$2,115,756
+11035.6%
2,074,271
+14828.2%
0.00%
Q3 2022$19,000
-60.4%
13,895
-61.5%
0.00%
Q2 2022$48,000
-59.7%
36,126
+21.3%
0.00%
Q1 2022$119,00029,7920.00%
Other shareholders
VINCERX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders